<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Why Guidance Will Not be the Most Important Thing to Come Out of the FDA Social Media Hearings</title>
	<atom:link href="http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/#utm_source=feed&#038;utm_medium=feed&#038;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Thu, 19 Jan 2012 21:23:35 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
	<item>
		<title>By: Elisheba Muturi</title>
		<link>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/comment-page-1/#comment-897</link>
		<dc:creator>Elisheba Muturi</dc:creator>
		<pubDate>Mon, 23 Nov 2009 00:33:13 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=68#comment-897</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;FDA Soc Media coverage  http://tr.im/FnQL supports @PRforPharma : key outcome = conversation not guidance http://bit.ly/4GyR3N&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">FDA Soc Media coverage  <a href="http://tr.im/FnQL" rel="nofollow">http://tr.im/FnQL</a> supports @PRforPharma : key outcome = conversation not guidance <a href="http://bit.ly/4GyR3N" rel="nofollow">http://bit.ly/4GyR3N</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: uberVU - social comments</title>
		<link>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/comment-page-1/#comment-109</link>
		<dc:creator>uberVU - social comments</dc:creator>
		<pubDate>Tue, 17 Nov 2009 13:50:20 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=68#comment-109</guid>
		<description>&lt;strong&gt;Social comments and analytics for this post...&lt;/strong&gt;

This post was mentioned on Twitter by PRforPharma: Why official guidance will not be the most important thing to come out of the FDA social media hearings: http://bit.ly/16xdHd...</description>
		<content:encoded><![CDATA[<p><strong>Social comments and analytics for this post&#8230;</strong></p>
<p>This post was mentioned on Twitter by PRforPharma: Why official guidance will not be the most important thing to come out of the FDA social media hearings: <a href="http://bit.ly/16xdHd.." rel="nofollow">http://bit.ly/16xdHd..</a>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Paulo Machado</title>
		<link>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/comment-page-1/#comment-898</link>
		<dc:creator>Paulo Machado</dc:creator>
		<pubDate>Tue, 17 Nov 2009 03:00:48 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=68#comment-898</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PRforPharma Why official guidance will not b the most important thing to come out of the FDA social media hearings: http://bit.ly/16xdHd&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PRforPharma Why official guidance will not b the most important thing to come out of the FDA social media hearings: <a href="http://bit.ly/16xdHd" rel="nofollow">http://bit.ly/16xdHd</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/comment-page-1/#comment-899</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Tue, 17 Nov 2009 02:47:04 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=68#comment-899</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Why official guidance will not be the most important thing to come out of the FDA social media hearings: http://bit.ly/16xdHd&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Why official guidance will not be the most important thing to come out of the FDA social media hearings: <a href="http://bit.ly/16xdHd" rel="nofollow">http://bit.ly/16xdHd</a></span></span></span></p>
]]></content:encoded>
	</item>
</channel>
</rss>

